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Abstract
Background: The Chronic Dispensing Unit (CDU) is an out-sourced, public sector centralised dispensing service
that has been operational in the Western Cape Province in South Africa since 2005. The CDU dispenses medicines
for stable patients with chronic conditions. The aim is to reduce pharmacists’ workload, reduce patient waiting
times and decongest healthcare facilities. Our objectives are to describe the intervention’s scope, illustrate its
interface with the health system and describe its processes and outcomes. Secondly, to quantify the magnitude of
missed appointments by enrolled patients and to describe the implications thereof in order to inform a subsequent
in-depth empirical study on the underlying causes.
Methods: We adopted a case study design in order to elicit the programme theory underlying the CDU strategy.
We consulted 15 senior and middle managers from the provincial Department of Health who were working closely
with the intervention and the contractor using focus group discussions and key informant interviews. In addition,
relevant literature, and policy and programme documents were reviewed and analysed.
Results: We found that the CDU scope has significantly expanded over the last 10 years owing to technological
advancements. As such, in early 2015, the CDU produced nearly 300,000 parcels monthly. Medicines supply, patient
enrollment processes, healthcare professionals' compliance to legislation and policies, mechanisms for medicines
distribution, management of non-collected medicines (emanating from patients’ missed appointments) and the array of
actors involved are all central to the CDU’s functioning. Missed appointments by patients are a problem, affecting an
estimated 8 %–12 % of patients each month. However, the causes have not been investigated thoroughly. Implications
of missed appointments include a cost to government for services rendered by the contractor, potential losses due to
expired medicines, additional workload for the contractor and healthcare facility staff and potential negative therapeutic
outcomes for patients.
Conclusions: The CDU demonstrates innovation in a context of overwhelming demand for dispensing medicines for
chronic conditions. However, it is not a panacea to address access-to-medicines related challenges. A multi-level
assessment that is currently underway will provide more insights on how existing challenges can be addressed.
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Background
Access to essential medicines is considered a fundamen-
tal part of universal health coverage and a key element
for the delivery of services and high-quality care [1]. A
2012 assessment of the South African health system
underscored the need to give a higher priority status to
medicines supply chains as they affect various dimen-
sions of access to medicines and health care utilisation
in general [2]. Although South Africa offers free primary
health care (PHC) services in the public sector, sub-
scribes to an essential medicines programme [3] and
provides free medicines at PHC level [4], there are per-
sistent challenges that hinder sustainable access to medi-
cines. The increasing burden of disease [5], coupled with
a general shortage and maldistribution of health profes-
sionals (private-public, urban–rural) [6], for example,
threaten the ability of supply chain systems to function
optimally. Shortages in all areas of pharmacy practice are
common. Vacancy rates for pharmacists in the public
sector of up to 76 %, were reported in one province and
only 29 % of pharmacists were working in the public
sector as of 2010 [7]. Various reforms and interventions
have been implemented to address shortages of
pharmacists, such as the introduction of incentives, the
impact of which is yet to be determined on pharma-
ceutical human resource trends [8] and new models of
centralised dispensing of medicines for chronic condi-
tions [9, 10]. In this article, we report on a centralised
dispensing intervention in the Western Cape Province,
in South Africa.
Western Cape Province’s response to strengthen access
to medicines
Each of South Africa’s nine provinces has its own legisla-
ture, premier and executive council, and specific popula-
tion and economical characteristics. The Western Cape
is South Africa’s most cosmopolitan province, with a
population of just under six million in 2011 [2]. The
2010 mortality profile reported that about 65 % of deaths
occurred in the metropolitan district of Cape Town [11],
which has the greatest proportion of patients and the
greatest pressure on health services [9]. HIV/AIDS and
non-communicable diseases (NCDs), account for a large
proportion of premature mortality [12]. The healthcare
system is two-tiered, consisting of a public and a private
sector. However, the vast majority of the population
(more than 75 %) is dependent on the public sector for,
inter alia, supply of medicines [13].
The Western Cape Department of Health (WCDoH)
established an out-sourced, centralised dispensing inter-
vention known as the Chronic Dispensing Unit (CDU).
Introduced in December of 2005, the CDU dispenses
medicines for stable, public- sector patients with the aim
to: reduce pharmacists’ workload (by relieving pharmacy
staff from repetitive and time consuming tasks that de-
tract from patient-focussed elements), decongest health
facilities (hereafter referred as facilities) and improve the
patient experience by reducing waiting times [9, 10].
The contractor, is responsible for specific supply chain
functions which are elaborated on in later sections of
this article.
The CDU was initially implemented as part of the prov-
ince’s first strategic vision for health care (Health Care
2010), which acknowledged the necessity to substantially
improve the quality of care of the health service, while
recognising that “One of the biggest challenges facing
the Department is the need to ensure that its workforce
meets the challenges of service delivery within a chan-
ging environment with a sizeable burden of disease.”
[14]. Since its establishment in 2005, the CDU has
remained a significant part of the province’s plans. The
current provincial strategy (Health Care 2030) states
that “…it is expected that the CDU will be well-
established in future and will assist to address the
increasing demand for efficient dispensing of chronic
medicines, which are expected to form the bulk of the
burden of disease in the next two decades” [15]. In light
of this, the CDU has been presented as part of the motiv-
ation for an increase in the health budget allocation [16],
and a huge financial investment towards this service has
been made. The current five-year contract between the
government and the contractor, which commenced in
2012, is valued at 500 million South African rands [17],
which was approximately 62,5 million United States dol-
lars in 2012.
Despite the leadership’s commitment and efforts, sev-
eral operational challenges exist. Among these chal-
lenges, the trend of missed appointments by patients is
a concern to the WCDoH and our study was commis-
sioned to investigate this issue. Within the context of
this intervention, the term “non-collected medicines” is
used to refer to pre-packed Patient Medicine Parcels
(PMPs) that are not picked up by patients on or close
to the scheduled date and are subsequently returned to
the CDU. Monthly collection statistics are a key moni-
toring indicator of the intervention’s performance.
In this paper, we provide a comprehensive description
of the operations of the CDU and seek to gain a better
understanding of the current issue of concer-
n—i.e. missed appointments. Earlier articles described
the CDU in its initial stages of implementation focusing
mostly on the dispensing processes [9, 10]. We set out
to elicit the programme theory (defined as processes
planned to achieve certain outcomes), which according
to Van Belle et al. [18] is useful for understanding com-
plex interventions. More specifically, this study aims to
identify the actors’ interpretations of how the CDU’s ac-
tivities are linked to the outcomes. Therefore, our
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objectives are: (1) to illustrate the CDU’s interface with
the health system and describe its coverage, dispensing
capacity and beneficiary profile; (2) to quantify the magni-
tude of missed appointments by patients and (3) to de-
scribe the implications thereof in order to inform a




We adopted the case study design. This approach is
appropriate because of the limited literature on the
intervention and the need to understand how certain
processes take place in order to comprehend the
phenomenon [19].
Data were collected from multiple sources using focus
group discussions, key informant interviews and docu-
ment and literature reviews. We consulted 15 purpos-
ively selected key informants: senior and mid-level
managers within the WCDoH involved in policy devel-
opment and implementation of the intervention; and the
current contracter (UTI Pharma).
The breakdown of respondents is provided in Table 1.
Key informant perspectives were complemented by a re-
view of published articles. We also carried out a review of
CDU-related documents, including service level agree-
ments, standard operating procedures, quarterly reports,
conference proceedings, press statements, academic theses
as well as routine data collected by the CDU. We devel-
oped a data collection tool that listed pre-determined
variables of interest (e.g. coverage, dispensing capacity,
demographics of beneficiaries and non-collected medi-
cines). It also contained open- ended questions on pro-
cesses and the issue of medicine non-collection. Data was
collected between 2013 and 2014.
We started the analysis of qualitative data by develop-
ing descriptive narrative accounts to map the interven-
tion processes. We analysed the quantitative data using
descriptive statistics in Microsoft Excel, including means
and frequencies on age, gender, coverage, dispensing
capacity and non-collected medicines. For data on non-
collected medicines, we focused only on 2014 data, post
introduction of the revised “returns policy” for health-
care facilities as data quality was expected to improve as
a result of the policy revisions. For validation, we used
member checking [20]. We circulated the draft manu-
script to implementers of the intervention and invited
comments.
Ethics approval for this study was granted by the
Senate Research Committee at the University of the
Western Cape (Ref: 11/7/8). Consent to interview and
record interviews was obtained from participants.
They were also informed of their right to withdraw
from the interview at any time. To ensure anonymity,
participants were assigned codes that were known
only by the first author.
Results
Implementation context
The administration of public sector health services in the
Western Cape Province falls under either of two jurisdic-
tions. The provincial authority (WCDoH) administers a
number of urban and rural facilities at the primary, sec-
ondary and tertiary levels of healthcare. The Cape Town
Metropolitan municipality administers most primary
healthcare clinics within its jurisdiction.
Healthcare facilities in this province rely on two com-
plementary methods of medicines dispensing. Tradition-
ally, patients with acute conditions and patients who
are not yet stabilised on therapy for chronic conditions
obtain their medicines at the dispensary of the health-
care facility that they use. On the other hand, the CDU
is designed to dispense medicines for stable patients.
Key informants estimated that about 60 % of all pa-
tients with chronic conditions in the province ob-
tained medicines through the CDU, although this is
yet to be verified empirically by the WCDoH. Medi-
cines dispensed by both the CDU and public-sector
healthcare facilities are sourced from the government-
owned Cape Medical Depot (CMD).
Mapping the intervention processes
We mapped the key processes between the CDU, the
CMD and healthcare facilities, and identified the corre-
sponding actors/stakeholders such as clinicians, the con-
tractor and patients. Furthermore, we identified each
actor’s responsibility and the relationships between the
different actors (Fig. 1). Full narrative descriptions of the
actors and processes are provided as Additional file 1.
Table 1 Study participants
Level Participant description Number of participants Research method used
Senior management Western Cape Department of Health personnel 3 1 focus group discussion
Middle management Sub-structure pharmacist managers 5 Key informant interviews
(2 face-to-face and 3 telephonic)
Implementation team and support Western Cape Department of Health personnel
and the contractor
7 2 focus group discussions
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Although we depicted one healthcare facility as an ex-
ample, this process is similar for all facilities registered
with the CDU.
An implementation team, comprising WCDoH personnel
and the contractor is at the core of the implementation
strategy. This team orients new facilities to CDU policies in
order to promote effective uptake of the intervention.
Thereafter, implementation support is maintained by liaison
officers appointed by the contractor to facilitate smooth
roll-out of the intervention.
Scope of the intervention
Coverage
The CDU has and continues to apply a phased approach to
enrolling healthcare facilities. Using various WCDoH re-
ports, we tracked the increase in this enrollment. The CDU
commenced with eight urban healthcare facilities in 2005.
By mid2008, just over 40 facilities were enrolled and later
that year, the incorporation of rural regions started. By the
end of 2013, over 100 facilities were enrolled, reaching 216
facilities in early 2015. The CDU more recently focused on
enrollment of rural facilities and supporting decentralised
pick-up points. Although PMPs are generally delivered to a
healthcare facility, actual distribution is also occurring at al-
ternative sites, such as mobile clinics, community clubs, old
age homes and workplaces, most of which are linked to the
nearest healthcare facilities. When healthcare facilities
register alternative distribution sites with the CDU, PMPs
are labelled seperately from those distributed from the
healthcare facilities. The CDU had 2724 registered alterna-
tive sites at the end of 2014.
Dispensing capacity
With an average of five to six items per prescription
(which are all packaged in one PMP), the CDU dis-
pensed over one million items each month in early 2015.
The first batch of PMPs in 2005 was 984 in total. This in-
creased to almost 20,000 PMPs by the end of 2006 and al-
most 80,000 by the end of 2007. Over the next 4 years (up
to 2011), 100 % growth occurred (80,000 to 160,000).
Growth slowed down to 25 % between 2011 and 2013
(160,000 to 200,000 per month). This was most likely due
Fig. 1 Mapping the process between the CDU and health facilities
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to the change-over processes to a different contractor.
Complexity of data transfer between the out-going and in-
coming contractors partly affected the new contractor's
ability to continue the service efficiently. This was further
compounded by the implementation of new business pro-
cesses and the commissioning of sophisticated dispensing
equipment [21]. For the first few weeks of the transition,
the new contractor and WCDoH jointly reverted to manual
dispensing as an interim measure. WCDoH suspended
some facilities from the CDU for about 3 months to allow
the service to stabilise again.
Between 2013 and 2014, the dispensing capacity steadily
increased with over 350,000 PMPs produced in October
2014. This high volume of PMPs was partially explained by
the four months’ supply of antiretroviral therapy to accom-
modate the December/January festive period which is asso-
ciated with patients travelling to their home provinces. The
dispensing volume per month in the first quarter of 2015
was approximately 300,000 PMPs.
About 77 % of PMPs were delivered to urban healthcare
facilities and 23 % to rural ones. The number of PMPs de-
livered to each facility ranged from under 1,000 to about
15,000 per site, per month. The increased dispensing cap-
acity was facilitated by technological advancements, includ-
ing largely automated processes for certain functions such
as picking, packaging and labelling of medicines.
Enrollment of patient beneficiaries
According to the procedure, patient enrollment should be
based on a clinician’s assessment of the patient’s clinical stabil-
ity. Patients who fail to achieve clinical stability and those with
conditions demanding more regular monitoring (e.g. certain
mental health conditions) or taking medicines requiring
stricter control (e.g. benzodiazepines) should be excluded.
Patient characteristics: age, gender and disease profile
In early 2015, the CDU had 213,682 active patients
(85 % urban and 15 % rural). Males constituted 34 %
and females 66 % of the cohort. Slightly more than 80 %
were over the age of 40 years, illustrating that the CDU
served a predominantly adult population (Fig. 2).
It was not possible to evaluate the disease patterns
from the CDU data since up to this point; the CDU does
not capture patient diagnosis data. However, dispensed
items were classified according to the Medi-Span Gen-
eric Product Identifier (GPI) classification. This is a hier-
archical identifier, which provides specific information
about medicines [22] and which may, to some extent,
provide insights into patient diagnosis. We found that in
2013 and 2014 anti-hypertensives, diuretics, anti-diabetic
agents, analgesics/antipyretics as well as bronchodilators
constituted more than 50 % of the items dispensed each
month. About 12 % of the PMPs contained HIV
treatment.
Missed appointments by CDU beneficiaries
At inception, a monthly allowance of 4 % "non-collection"
was factored in to accommodate for loss-to-follow-up or
death. However, we found that for the year 2014, an esti-
mated 8 % to 12 % of PMPs were returned to the CDU as
a result of non-collection. These were likely to be conser-
vative estimates, since many facilities under-reported on
collection statistics: the percentage of facilities that duly
reported each month was only in the range of 24 % to
67 %. Furthermore, rural areas were excluded in the ana-
lysis since enrollment of most facilities was recent and the
intervention had not stabilised. Some key informants sus-
pected that since PMP collection statistics were regarded
as a performance indicator, there was a disincentive to re-
port statistics that could potentially be viewed nega-
tively. In 2014, the WCDoH revised the “returns policy”,
requiring healthcare facilities to strictly adhere to the
returns time-frame i.e. within 10 working days from the
scheduled collection date. Previously, some healthcare fa-
cilities kept non-collected PMPs for months to over a year
before returning them to the CDU.
We found that missed appointments had several impli-
cations. First, medicines expired before they could be
redistributed by the CDU. Second, the CDU’s average
monthly consumption data were being distorted and
subsequently impacted negatively on forecasting. Third,
missed appointments imposed a financial burden on the
government as the service provider is paid on a “fee-per-
PMP-delivered” basis, meaning that every PMP that is
not collected is still to be paid for yet it does not reach
the patient. Fourth, missed appointments increased the
contractor’s workload due to additional administrative
processes and the efforts required to re-integrate stock
into the dispensing system. At the healthcare facility
level, missed appointments also generated more work
for the pharmacy personnel, as they had to absorb medi-
cines into the local pharmacy (if PMPs were not
returned to the CDU). Furthermore, facility-based phar-
macists dispensed medicines from the pharmacy or dis-
pensary if the patient presented late and in some cases
Fig. 2 Distribution of CDU beneficiaries by age and gender
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the clinician also had to consult with the defaulter pa-
tient. This undermined the efficiency benefit of the
CDU. Finally, there were concerns of possible negative
outcomes if patients missed appointments and subse-
quently defaulted on treatment.
We enquired about the possibility of identifying “best
practice” facilities for benchmarking purposes. Key infor-
mants suggested that missed appointments were a wide-
spread problem and that the variation between facilities was
difficult to discern because of under-reporting, as alluded to
earlier. However, respondents suggested that inclusion of
urban healthcare facilities in benchmarking attempts was
more ideal as the intervention has entered into the routine
stage in these facilities. Cohort size was also perceived to in-
fluence patient management practises, i.e. larger patient co-
horts were presumably more challenging to manage. One
informant said, “If you can solve it for these (large) sites, then
you have solved it for the rest.” There was a general interest
to focus on improving collection of medicines for treating
NCDs, since the disease burden was higher than that of
HIV in this province and disease programmes were presum-
ably much less developed for NCDs than for HIV.
Discussion
This paper describes the gradual expansion of the CDU over
the last 10 years. It also shows how missed appointments by
patients are an important problem in CDU implementation
[9] and that the causes of this have not been investigated
thoroughly. In general, limited studies have been conducted
on the CDU, there are no baseline data and a comprehen-
sive evaluation is yet to be conducted. To prepare for further
in-depth research, we carried out this exploratory case
study, which provides a detailed description of the actors
and components of the intervention. It points to some pre-
liminary explanations about how the CDU is expected to
work (the underlying assumptions, planned intervention
and expected results). It also shows how the programme is
actually running and it explored the actual results.
This study has some limitations. First, we are as of yet
unable to present clear trends of missed appointments.
Data quality was questionable due to under-reporting by
healthcare facilities and conflicting data sources. In
addition, data on patient diagnosis and outcomes which
could have informed some aspects of our study have
not been captured up to this point.
Despite these limitations, our preliminary results are
in line with the (scant) publications. Missed appoint-
ments are not a new phenomenon to this intervention
[9] or in healthcare provision in general [23–27]. If the
same problem has persisted, what should be done differ-
ently to attain a different outcome? Some authors have
suggested that unexpected results could be because a
good intervention theory is not being carried out well or
the problem is the theory itself [28]. In the case of the
CDU, existing evidence suggests to some degree that the
CDU objectives have been achieved and cite benefits such
as reduced waiting times [9, 10, 29], patients’ improved
experiences with healthcare services and their motivation
to remain stable, increased time for patient counselling [9,
10], and pharmacists’ ability to serve more than double
the number of people they served prior to CDU imple-
mentation [29]. Despite these reported benefits, how-
ever, we report the difficulty to ascertain how most of
the conclusions were reached, the sustainability of the
gains and the inability to generalise the findings. There
are also differing views which show that implementa-
tion results might be variable. For instance, Munyikwa’s
study found that pharmacists’ workload had not de-
creased as anticipated. Instead, pressure shifted from
dispensing to managerial and administrative tasks and
pharmacists reported that the patient base had in-
creased. As a result, time for patient counselling was
still limited. In addition, only a few patients reported
reduced travelling costs [29]. This was not surprising
given that the sample only consisted of patients who
collected medicines from the healthcare facility and not
from alternative sites in the community.
Implications for further research
There is a dearth of literature on models of centralised
dispensing. Also, out-sourcing of selected supply chain ac-
tivities is considered to be minimal in low-and-middle-in-
come countries [30]. While we are aware that centralised
dispensing occurs in the private sector in other countries,
particularly high-income countries, this has not been doc-
umented in Africa. To our knowledge, the CDU is the
first public sector, large-scale, centralised dispensing
model in South Africa, and the only such model in Af-
rica. As a result, implementing it without experiences
from similar interventions to learn from was cited as a
challenge [9]. However, despite this limited evidence, -
centralised dispensing is gaining momentum in South
Africa, especially as a part of the on-going National Health
Insurance pilot programme in other South African prov-
inces [31]. This underscores how centralised dispensing is
a preferred strategy for improving access to medicines for
public- sector patients in South Africa [32]. This paper ad-
vances the understanding of the CDU and lays a founda-
tion for future work that aims to improve the intervention
and provide lessons for similar models. This is crucial be-
cause the challenges that led to the establishment of the
CDU are not unique to South Africa. Many countries with
low economic indicators tend to have relatively similar
challenges in their health systems [33].
The lack of evidence to explain possible causes for
missed appointments call for in-depth research into
CDU implementation. Placing the known implementa-
tion problem (in this case, missed appointments) as a
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starting point to enquiry has been cited as a useful way
to understanding interventions [28]. It is likely that im-
plementation results will be variable across healthcare
facilities. Investigating facility-specific characteristics,
such as human resources, infrastructure and staff motiv-
ation [34] and the impact of the intervention on the
healthcare provider, patient access to treatment and dif-
ficulties in implementation could also be necessary [35].
Conclusion
The CDU in the Western Cape province in South Africa
reflects innovation in organisation, structure and delivery
of healthcare in a middle- income country with a substan-
tial demand for medicines for chronic conditions. Such a
model has the potential to increase access to medicines in
other settings. However, it is not a panacea for overcoming
all challenges pertaining to access to medicines. This study
informed a multi-level assessment that is currently under-
way to understand the problem of missed appointments
within the context of implementation related factors.
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